Search - tctmd.com

Displaying 141 - 160 of 699

Sort: Relevancy | Date

Presentation TCT 2023

TCT 267: Pooled, 12-month Blood Pressure Reductions Using the Symplicity Spyral Radiofrequency Renal Denervation Catheter

Presenter: Felix Mahfoud

October 25, 2023

Presentation TCT 2023

TCT 244: Impact of Online Educational Series on Interventional Innovations in Blood Pressure Control

Presenter: Ron miller

October 25, 2023

Presentation TCT 2023

TCT 640: Trends in Patients With and Without End Stage Renal Disease Undergoing Transcatheter Edge-To-Edge Mitral Valve Repair

Presenter: Ufuk Vardar

October 25, 2023

Presentation TCT 2023

TCT 3: Renal Artery Denervation Combined with Pulmonary Vein Isolation in Patients with Heart Failure and Atrial Fibrillation - Pilot Study

Presenter: Tomasz Skowerski

October 25, 2023

Presentation TCT 2023

TCT 228: Three-year outcomes between patients with acute myocardial infarction, with and without obstructive coronary artery disease, according to renal function

Presenter: Yong Hoon Kim

October 25, 2023

Presentation TCT 2023

TCT 946: Mechanical Thrombectomy of a Cavoatrial Tumor Thrombi Using the AlphaVac System in Renal Cell Carcinoma

Presenter: Akruti Prabhakar

October 25, 2023

Presentation TCT 2023

TCT 726: Efficacy of Renal Denervation and antihypertensives in patients with resistant hypertension: A systematic review and Network meta analysis

Presenter: Hamza Naveed

October 25, 2023

Presentation TCT 2023

TCT 398: Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Six-Month Results Following Blinded Medication Titration in the Randomized, Sham-Controlled RADIANCE II Pivotal Trial

Presenter: Michel Azizi

October 25, 2023

Presentation TCT 2023

TCT 210: Long-term Safety and Efficacy of Endovascular Ultrasound Renal Denervation in Resistant Hypertension: 8-year results from the ACHIEVE study

Presenter: Victor Zeijen

October 25, 2023

Presentation TCT 2023

TCT 207: Prediction of Six- and Twelve-Months Blood Pressure Results After Renal Denervation for Arterial Hypertension

Presenter: Karl Fengler

October 25, 2023

Presentation TCT 2023

TCT 152: Echocardiographic Findings Following Renal Sympathetic denervationfor treatment resistant hypertension, The ReShape CV-risk study.

Presenter: Anna Subbotina

October 25, 2023

Presentation TCT 2023

Are Outcome Trials Necessary for Renal Denervation Therapies?

Presenter: Ajay Kirtane

October 24, 2023

Presentation TCT 2023

What Will the Next Trial Designs Look Like for Renal Denervation?

Presenter: Eric Secemsky

October 24, 2023

Presentation TCT 2023

Clinician Perspectives

Presenter: Naomi Fisher

October 24, 2023

Presentation TCT 2023

Industry Perspectives

Presenter: Sandeep Brar

October 24, 2023

Presentation TCT 2023

Trialist Perspectives

Presenter: Felix Mahfoud

October 24, 2023

Presentation TCT 2023

TCT 774: Predictors of Complete Heart Block in Patients With end Stage Renal Disease Undergoing Transcatheter Aortic Valve Replacement

Presenter: Errol Moras

October 24, 2023

Presentation TCT 2023

From First Gen to Next Gen: New Devices on the Horizon

Presenter: Felix Mahfoud

October 24, 2023

Presentation TCT 2023

Securing Reimbursement: The Pathway to Financial Stability

Presenter: David Kandzari

October 24, 2023

Presentation TCT 2023

Creating Training Pathways for the Proceduralist

Presenter: Herbert Aronow

October 24, 2023

Advertisement

TCT 267: Pooled, 12-month Blood Pressure Reductions Using the Symplicity Spyral Radiofrequency Renal Denervation Catheter

TCT 244: Impact of Online Educational Series on Interventional Innovations in Blood Pressure Control

TCT 640: Trends in Patients With and Without End Stage Renal Disease Undergoing Transcatheter Edge-To-Edge Mitral Valve Repair

TCT 3: Renal Artery Denervation Combined with Pulmonary Vein Isolation in Patients with Heart Failure and Atrial Fibrillation - Pilot Study

TCT 228: Three-year outcomes between patients with acute myocardial infarction, with and without obstructive coronary artery disease, according to renal function

TCT 946: Mechanical Thrombectomy of a Cavoatrial Tumor Thrombi Using the AlphaVac System in Renal Cell Carcinoma

TCT 726: Efficacy of Renal Denervation and antihypertensives in patients with resistant hypertension: A systematic review and Network meta analysis

TCT 398: Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Six-Month Results Following Blinded Medication Titration in the Randomized, Sham-Controlled RADIANCE II Pivotal Trial

TCT 210: Long-term Safety and Efficacy of Endovascular Ultrasound Renal Denervation in Resistant Hypertension: 8-year results from the ACHIEVE study

TCT 207: Prediction of Six- and Twelve-Months Blood Pressure Results After Renal Denervation for Arterial Hypertension

TCT 152: Echocardiographic Findings Following Renal Sympathetic denervationfor treatment resistant hypertension, The ReShape CV-risk study.

Are Outcome Trials Necessary for Renal Denervation Therapies?

What Will the Next Trial Designs Look Like for Renal Denervation?

Clinician Perspectives

Industry Perspectives

Trialist Perspectives

TCT 774: Predictors of Complete Heart Block in Patients With end Stage Renal Disease Undergoing Transcatheter Aortic Valve Replacement

From First Gen to Next Gen: New Devices on the Horizon

Securing Reimbursement: The Pathway to Financial Stability

Creating Training Pathways for the Proceduralist

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content